Efthymios (Timos) Ziogos
@tziogos
Post-Doctoral Research Fellow @hopkinsheart with @TLeucker and Gary Gerstenblith | MD
ID: 1188050491110035457
26-10-2019 11:11:40
69 Tweet
158 Followers
338 Following
A short break from malignant heme to explore liver outcomes in People with Hemophilia and HCV at #ASH23. Honored to be awarded with an ASH Abstract Achievement Award. Very grateful for Dr. Ragni’s mentorship! Pitt Medicine Chiefs Pitt General Internal Medicine UPMC Hillman Cancer Center UPMC Hematology & Oncology Fellowship Program ASH
Energetic Basis of Recovered EF in Human HF | Circulation ahajournals.org/doi/10.1161/CI…… 🔥off the press: Insightful paper on prediction of LV recovery in non-ischemic CM with myocardial energetics Congrats to Joseph Goldenberg, MD PhD lead author, T32 fellow Johns Hopkins Cardiology CardioNerds Society for Cardiovascular Magnetic Resonance
Super congrats to the Johns Hopkins Cardiology Fellowship Director & the Franz Beckenbauer Specialist in Vascular Biology on his Promotion Today to Associate Professor of Medicine! The Johns Hopkins Ciccarone Center & the Milwaukee Bucks are so happy for Thorsten Leucker & Marie! #🥍🏏⚽️
A new, very good review on #LongCovid's cardiovascular effects nature.com/articles/s4416… Erin Goerlich Allison G. Hays, MD Johns Hopkins Cardiology Nature Cardiovascular Research
Incredible honored and elated to be joining the amazing family of The Osler Medical Residency JHU PSP!!! Immensely grateful to my wonderful mentors and friends, Thorsten Leucker, Gary Gerstenblith, Steven Schulman, Allison G. Hays, MD, Tarek Harb, Michael A. Vavuranakis, and so many more Johns Hopkins Cardiology
Proud of our IM resident Christos P. Kyriakopoulos presenting 2 abstracts on characteristics associated with successful outcomes for ADHF-CS patients and CS transfers #ACC24 Joseph Taleb Konstantinos Sideris Rana Hamouche Caroline Milne Thomas Hanff, MD MSCE Utah IM CMRs @UofCV UofU CT Surgery
Extremely proud of my better half Maria Ioannou who gave a terrific talk in the C3PO Lecture Series on MEK inhibition in glioblastoma!
Thrilled to see the hard work of Maria Ioannou in press for the world to see! Exploiting the role of #NF1 in #GBM with combined therapy bring us one step closer to helping patients #cureGBM Johns Hopkins Kimmel Cancer Center aacrjournals.org/mct/article-ab…
Thrilled to see our work on how MEK inhibition enhances the anti-tumor effect of radiation therapy in GBM, published in Molecular Cancer Therapeutics. Special thanks to Dr. Schreck, Christine Pratilas MD, Abiola for their support and guidance! #NF1 #GBM #cureGBM 🧠
Happy to share our latest work with Dr. Schreck on State of the Art in Low-Grade Glioma Management: Insights From Isocitrate Dehydrogenase and Beyond | that you can read about on American Society of Clinical Oncology Educational Book ascopubs.org/doi/10.1200/ED…
Excited to share our recent publication studying hospital readmissions in patients on LVAD support !! Theo Giannouchos Konstantinos Sideris Thomas Hanff, MD MSCE Josef Stehlik Stavros George Drakos Craig Selzman & Matt Goodwin UofU Cardiology UofU CT Surgery University of Utah Department of Internal Medicine mdpi.com/2787094 via JCM MDPI
Excited to share our labs research on targeted therapy for MPNST (Ava Wang); characterization of the immune microenvironment Lindy Zhang, MD PhD ; and the JH NF Biospecimen repository Stavriani Makri, MD at the NF conf in Brussels #NFcon24 #EndNF Children's Tumor Fdn Neurofibromatosis Therapeutic Acceleration Program Johns Hopkins Kimmel Cancer Center
Advanced biological 💊Rx💉 reduces ASCVD 🫀events in patients with IBD. Collaborative work Johns Hopkins Cardiology Johns Hopkins Gastroenterology & Hepatology Tarek Harb Lara Chaaban Joanna Melia #ESCCongress2024
🔥off the press #ESCCongress2024 intraindividual variability in Lp(a) presented by 🌟fellow Tarek Harb and simultaneous publication in EHJOpen Editor-in-Chief ‼️Maciej Banach Johns Hopkins Cardiology American University of Beirut Johns Hopkins Ciccarone Center The Osler Medical Residency
👉🏻Our study suggests repeat Lp(a) tests 🧪could be crucial for those in the #society_eas intermediate risk group. 53% could be reclassified with a second test. Time to rethink cardiovascular risk assessment. European Atherosclerosis Society EHJOpen Editor-in-Chief American Heart Association American College of Cardiology Tarek Harb